BAUMGARTNER RUDOLF A.,MCVICAR WILLIAM K.,KIM NORMAN N.,MCCAULEY THOMAS
申请号：
NZ70062911
公开号：
NZ700629A
申请日:
2011.01.11
申请国别(地区):
NZ
年份:
2016
代理人:
摘要：
The present disclosure is directed to a combination or a kit comprising a prostaglandin analog and an adenosine receptor A1 agonist of formula (I) and to a method of reducing intraocular pressure (IOP) in a subject using such combination or kit. The disclosire is particularly directed to a combination of latanoprost marketed under the brand Xalatan TM and Compound A.
